Curcumin and Gemcitabine in Patients With Advanced Pancreatic Cancer
Ron Epelbaum(University of Bern), Gil Bar‐Sela(Emek Medical Center), Moshe Schaffer(Rambam Health Care Campus), B. Vizel(Rambam Health Care Campus), Vladimir Badmaev(American Medical Research)
Cited by 279
Related Papers
Curcumin as an Anti-Cancer Agent: Review of the Gap Between Basic and Clinical Applications
|Current Medicinal Chemistry|2009|480
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers
|British Journal of Cancer|2014|444
<sup>18</sup>F-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients
|Journal of Nuclear Medicine|2009|381
Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma
|Nature Medicine|2019|328